Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
BACKGROUND: Campath 1H is a depleting, humanized anti-CD52 monoclonal antibody that has now been used in 31 renal allograft recipients. The results have been very encouraging and are presented herein. METHODS: Campath 1H was administered, intravenously, in a dose of 20 mg, on day 0 and day 1 after...
Những tác giả chính: | Calne, R, Moffatt, S, Friend, P, Jamieson, N, Bradley, J, Hale, G, Firth, J, Smith, K, Waldmann, H |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1999
|
Những quyển sách tương tự
-
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.
Bằng: Calne, R, et al.
Được phát hành: (1998) -
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
Bằng: Watson, C, et al.
Được phát hành: (2005) -
Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
Bằng: Friend, P, et al.
Được phát hành: (1991) -
CAMPATH-IH in multiple sclerosis.
Bằng: Moreau, T, et al.
Được phát hành: (1996) -
Campath 1H (alemtuzumab) in renal transplantation: 5-year comparative follow up.
Bằng: Watson, C, et al.
Được phát hành: (2004)